"We have worked with Lauri Mitchell for over ten years, and she has been instrumental in not only driving discrete analytic projects but in shaping our research priorities and providing deep insight on an ever-expanding range of issues related to prescription drug utilization.  Lauri is both a gifted analyst and a strong project manager.  This unique combination of analytical expertise, strategic thinking, and ability to communicate clearly with senior executives makes her the clear choice for both short term projects and to manage large scale efforts."

Jenny Bryant
Senior Vice President, Policy and Research

Client Testimonials

"I have had the pleasure of working with Lauri Mitchell in her capacity as a consultant to the pricing and contracting organization at GlaxoSmithKline since 2009.  Throughout that period, as the pharmaceutical industry consolidated and margins compressed, contracting strategy became a critical driver of performance.   With millions of dollars in the balance, contracting analytics became a boardroom issue.  Lauri's leadership helped us make the transformation from intuitively-based pricing/contracting decisions to fact-based, analytically sound ones.  Her experience and deep understanding of the data, analytics, and issues allowed her to work effectively at all levels, from the executive suite to the contracting floor."

Jerry Osborne
Director, Applied Pricing and Analytics

Lauri MiTChell​, founder and managing director

​Lauri Mitchell is a seasoned advisor to leaders in the U.S. healthcare industry, with over 25 years of experience designing and conducting analytically-based studies to provide both strategic and operational guidance to key decision-makers. With a particular focus on the U.S. biopharmaceutical industry, Lauri has deep knowledge and understanding of the evolving landscape and its impact on the behavior of key industry participants - patients, providers and payers.

Lauri was a co-founder of The Amundsen Group, a boutique consulting firm focused on managed markets analytics, helping lead it through 9 years of growth before its acquisition by IMS Health in 2013. Her depth of experience, understanding of the application and integration of data to inform decision-making, and hands-on approach make her an invaluable asset to any organization. 

Lauri received her Master's in Management from Sloan School of Management at MIT.